Celadon Pharmaceuticals PLC (CEL) — Capital Reinvestment Ratio

Latest as of June 2020: 1.27x

Celadon Pharmaceuticals PLC (CEL) has a Capital Reinvestment Ratio of 1.27x as of June 2020, meaning it reinvests 1% of its operating cash flow (GBX109.70K) in capital expenditures (GBX139.75K). See CEL equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.27x

Capex / Operating Cash Flow

Operating Cash Flow

GBX109.70K

GBX

Capital Expenditures

GBX139.75K

GBX

Data as of

Jun 2020

Most recent filing

Annual Capital Reinvestment Ratio for Celadon Pharmaceuticals PLC (None–None)

Year-by-year Capital Reinvestment Ratio for Celadon Pharmaceuticals PLC from None to None. For live market cap and broader valuation context, see CEL stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow